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1726-4Catheter ablation in the role of rescuer in treatment of recurrent
atrial fibrillation following surgical ablationAtrial fibrillation (AF) is the most common cardiac
arrhythmia in clinical practice, which can induce cardiac
dysfunction and strokes, causing a substantial socioeconomic
burden.1,2 Patients with AF undergoing cardiac surgery have
an increased risk of ventricular dysfunction, comorbidities,
and mortality.3 Eradicating AF during cardiac surgery could
decrease the number of adverse cardiovascular events and
improve clinical outcome. Although the Cox-Maze procedure
is highly successful in maintaining sinus rhythm,4 its difficulty
and complexity reduces the procedure’s utilization by cardiac
surgeons in cardiovascular surgery.5 Surgical ablation using a
variety of energy sources such as radiofrequency (RF) energy,
microwave, cryoablation, laser, and high-intensity ultrasound,
has been widely utilized to create the linear lines which sim-
plify the procedure, and thus is typically more feasible than
the Cox-Maze procedure for most surgeons.5 Bipolar RF
delivers energy between two closely approximated electrodes
embedded in the jaw of a clamp device, creating discrete
linear lesions and is commonly applied in surgical ablation of
AF. However, the limitation of bipolar RF ablation is that it
can only clamp the tissue within the jaws of the device, and an
incomplete block might occur in some linear lesions. The
success rates in treatment of AF using bipolar ablation with
concomitant cardiac surgery varied from 65% to 95% fol-
lowing a 6-month follow-up.6 Surgical experience, differing
ablation technologies, and inconsistent definitions of proce-
dural success and follow-up could cause the discordant results.
Pulmonary vein (PV) isolation with more extensive lesion sets
including mitral isthmus line and biatrial lines, has been
reported to provide a better long-term outcome than PV iso-
lation only.7 A recent meta-analysis study showed that surgical
ablation had a lesser incidence of recurrent AF compared to
catheter ablation at 6 months [73% vs. 61%; Odds Ratio (OR),
2.19; 95% confidence interval (CI) 1.21e3.96; p ¼ 0.01] and
12 months (74% vs. 43%; OR, 3.91; 95% CI, 2.38e6.42;
p < 0.00001).8 The incidence of pacemaker implantation was
higher in surgical ablation versus catheter ablation, but no
difference in the frequency of stroke or cardiac tamponade was
noted. A blinded, large, multicenter, randomized, control trial
is needed to compare the efficacy of surgical and catheter
ablation in the treatment of AF.
In this issue of the JCMA, Mamchur et al9 reported the
efficacy of catheter ablation for recurrent AF after surgicalx.doi.org/10.1016/j.jcma.2014.04.005
901/Copyright  2014 Elsevier Taiwan LLC and the Chinese Medical Assablation in patients with mitral valve replacement by biological
prosthesis. PV reconnection was found in all recurrent patients.
Interestingly, the reisolation of PVs contributed to sinus
rhythm restoration in 4 of 10 patients, and additional ganglionic
plexi ablation restored sinus rhythm in two cases. In the other
four patients, AF transformed to atypical flutter and linear
ablation was created at the left atrial (LA) roof to achieve
restoration of sinus rhythm. No dysfunction of the prosthetic
valve was detected. Wazni et al10 studied 23 patients with
recurrence of arrhythmia after Maze surgery, and reported that
one-third of patients had recurrent AF due to PV reconnection,
22% had recurrent atrial tachycardia, and 43% had a recurrent
atrial flutter. Ninety-six percent of patients were treated suc-
cessfully with RF catheter ablation, and 83% of patients were
free from AF without antiarrhythmic drug at 1-year follow-up.
The conduction gap in the ablation or suture line is an impor-
tant mechanism of recurrent atrial tachyarrhythmia. These non-
transmural lesions could causeAFor reentrant atrial tachycardia.
PV reconduction was the major mechanism in patients with
recurrent atrial tachyarrhythmia after catheter ablation.5,11
Absence or dissociation of PV potentials recorded from a
circular mapping catheter is the procedural endpoint of PV
isolation.5 Reduction of local bipolar amplitude of 90% or
0.05 mV inside the encircled area has been reported as an
alternative endpoint for circumferential PV.5,12 With three-
dimensional anatomic mapping, higher bipolar voltage
recording may reflect thick atrial musculature. The larger
decrease in bipolar voltage could be suggestive of deeper
ablation lesions.12 Comprehensive electroanatomic mapping
to identify the gap, reentrant circuit, or non-PV foci followed
by RF ablation is still the most effective approach to eliminate
recurrent tachyarrhythmias. Recurrent atrial tachyarrhythmias
including AF, reentrant, and focal atrial tachycardia can be
successfully eliminated by repeat catheter ablation with a
desirable outcome.11 Mamchur et al’s9 study provides a clin-
ical significance to recurrent AF management after surgical
ablation in patients with mitral valve replacement, suggesting
that percutaneous catheter ablation and mapping for recurrent
tachyarrhythmia is safe, efficient, and feasible with an excel-
lent acute and long-term outcome. It can be offered to
symptomatic AF patients who failed surgical ablation.
Surgical ablation plays an important role in AF patients
with valvular heart disease undergoing operation.ociation. All rights reserved.
394 Editorial / Journal of the Chinese Medical Association 77 (2014) 393e394Percutaneous catheter ablation could play a role of rescuer,
which can identify the gaps of linear lesions and confirm the
complete block. With this modality, a better outcome can be
achieved in AF patients with cardiac surgery.
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